SCHEMBL8556673

SCHEMBL8556673

N#Cc1c(CCO)nn(-c2ccccc2)c1NC(=O)NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 5/20 0.40
ALOX5 P09917 5/20 0.40
KDR P35968 2/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
CA4 P22748 2/20 0.38
CA7 P43166 2/20 0.38
STS P08842 1/20 0.37
NTRK1 P04629 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
ALDH1A1 P00352 2/20 0.36
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554369 0.90 GAA (0.46) PTGESALOX5KDRFLT1FLT4
SCHEMBL8553174 0.90 PTGES (0.43) PTGESALOX5KDRFLT1FLT4
SCHEMBL8553246 0.89 NTRK1 (0.39) PTGESALOX5KDRFLT1FLT4
SCHEMBL7355477 0.85 STS (0.40) PTGESALOX5KDRFLT1FLT4
SCHEMBL1984012 0.85 NTRK1 (0.48) PTGESALOX5KDRFLT1FLT4
SCHEMBL8557168 0.84 GAA (0.44) PTGESALOX5STSNTRK1ALDH1A1
SCHEMBL8552075 0.83 FPR1 (0.41) PTGESALOX5KDRFLT1FLT4
SCHEMBL8552811 0.82 FPR1 (0.45) L3MBTL1NTRK1ALDH1A1LMNATSHR
SCHEMBL8556018 0.81 LMNA (0.48) L3MBTL1NTRK1ALDH1A1LMNAKMT2A
SCHEMBL8555845 0.80 LMNA (0.47) PTGESALOX5L3MBTL1NTRK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885890-A1 SULFONYLUREIDOPYRAZOLE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-12-23 EP disclosed